[Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
R M
RM
Guinovart
J M
JM
Carrascosa
C
C
Ferrándiz
D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D007117:Immunization, Secondary; D015477:Leukemia, Myelomonocytic, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D017254:Leukemic Infiltration / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000532:radiotherapy; D051917:Leukosialin / Q000032:analysis; D008297:Male; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D012772:Shock, Septic / Q000209:etiology; D012867:Skin / Q000473:pathology*; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000009:adverse effects*; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D003561:Cytarabine; D005047:Etoposide; D015255:Idarubicin; D051917:Leukosialin; D013745:Tetanus Toxoid; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C465014:SPN protein, human